IBKR:NASDAQInteractive Brokers Group, Inc. Analysis
Data as of 2026-06-20 - not real-time
$96.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Interactive Brokers (IBKR) is trading at $96, comfortably above its 20‑day SMA of 87.54, 50‑day SMA of 83.48 and 200‑day SMA of 72.19, indicating a strong bullish alignment. The MACD line (3.11) sits above its signal (2.36) with a positive histogram, while the RSI is at 70.8, signaling near‑overbought conditions and suggesting a short‑term pull‑back risk. Beta of 1.90 and 30‑day volatility of 35.7% underscore heightened price swings, yet volume is trending lower, hinting at waning short‑term momentum.
Fundamentally, IBKR boasts a 16.8% revenue growth rate, a gross margin of 93%, and an operating margin of 77%, delivering a solid profit margin of 16%. The forward PE of 33.4 versus the industry average of 16.9 points to growth pricing, but the discounted cash‑flow fair value of $237.5 suggests the stock is considerably undervalued, with an upside potential well above current levels despite a modest –8% downside metric. Strong cash reserves ($124.6 B), low payout ratio (13.7%) and a sustainable dividend (0.36%) further reinforce a resilient financial profile, while recent product launches and IPO participation opportunities add to the growth narrative.
Fundamentally, IBKR boasts a 16.8% revenue growth rate, a gross margin of 93%, and an operating margin of 77%, delivering a solid profit margin of 16%. The forward PE of 33.4 versus the industry average of 16.9 points to growth pricing, but the discounted cash‑flow fair value of $237.5 suggests the stock is considerably undervalued, with an upside potential well above current levels despite a modest –8% downside metric. Strong cash reserves ($124.6 B), low payout ratio (13.7%) and a sustainable dividend (0.36%) further reinforce a resilient financial profile, while recent product launches and IPO participation opportunities add to the growth narrative.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish alignment with all major SMAs
- RSI near overbought territory
- Decreasing volume trend indicating potential short‑term consolidation
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant undervaluation versus DCF fair value
- Robust revenue and profit margin growth
- Strategic product expansions (Agentic Trading integration, IPO access)
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong cash generation and low dividend payout ratio
- Sustained high operating margins and ROE
- Long‑term market position in capital markets with global client base
Key Metrics & Analysis
Financial Health
Revenue Growth16.80%
Profit Margin16.11%
P/E Ratio41.2
ROE23.56%
ROA2.42%
Debt/Equity152.19
P/B Ratio7.7
Op. Cash Flow$16.8B
Industry P/E16.9
Technical Analysis
TrendBullish
RSI70.8
Support$79.12
Resistance$97.81
MA 20$87.54
MA 50$83.48
MA 200$72.19
MACDBullish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Fair Value$237.49
Target Price$88.27
Upside/Downside-8.05%
GradeUndervalued
TypeGrowth
Dividend Yield0.36%
Risk Assessment
Beta1.90
Volatility35.74%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.